Vona, B;
Maroofian, R;
Bellacchio, E;
Najafi, M;
Thompson, K;
Alahmad, A;
He, L;
Ahangari, N;
Rad, A;
Shahrokhzadeh, S;
et al.
Vona, B; Maroofian, R; Bellacchio, E; Najafi, M; Thompson, K; Alahmad, A; He, L; Ahangari, N; Rad, A; Shahrokhzadeh, S; Bahena, P; Mittag, F; Traub, F; Movaffagh, J; Amiri, N; Doosti, M; Boostani, R; Shirzadeh, E; Haaf, T; Diodato, D; Schmidts, M; Taylor, RW; Karimiani, EG
(2018)
Expanding the clinical phenotype of IARS2-related mitochondrial disease.
BMC Med Genet, 19 (1).
p. 196.
ISSN 1471-2350
https://doi.org/10.1186/s12881-018-0709-3
SGUL Authors: Maroofian, Reza
Abstract
BACKGROUND: IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies. METHODS: Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis. RESULTS: Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein. CONCLUSIONS: This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia.
Item Type: |
Article
|
Additional Information: |
© The Author(s). 2018
Open Access
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: |
Adrenal insufficiency, CAGSSS, Cataracts, Growth hormone deficiency, IARS2, Sensorineural hearing loss, Sensory neuropathy, Skeletal dysplasia, Type II esophageal achalasia, 0604 Genetics, 1103 Clinical Sciences, Genetics & Heredity |
SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
Journal or Publication Title: |
BMC Med Genet |
ISSN: |
1471-2350 |
Language: |
eng |
Dates: |
Date | Event |
---|
12 November 2018 | Published | 25 October 2018 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
Projects: |
|
PubMed ID: |
30419932 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/110408 |
Publisher's version: |
https://doi.org/10.1186/s12881-018-0709-3 |
Statistics
Item downloaded times since 22 Nov 2018.
Actions (login required)
|
Edit Item |